Found 7 matching trials
Pre-Operative Treatment in REseCTable COlon CanceR
PHASE3This is an open-label, randomized, controlled, multicenter, phase III study...
Location
Charité Universitätsmedizin Berlin
Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer
N/AThis study was designed as multi-center, ambispective observational trial t...
Location
Qilu hospital of Shandong University
Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
PHASE3Evidence suggests that the addition of cetuximab or bevacizumab to doublet ...
Location
Zhongshan Hospital, Fudan University
Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer
PHASE2The purpose of this research is to see if adjusting the dose of 5-fluoroura...
Location
Inova Health Care Service
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
PHASE3Preoperative radiation with single agent chemotherapy as sensitizer is the ...
Location
Multiple Locations
mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer
PHASE2This study will focus on postoperative patients of stage IIIB or stage IIIC...
Location
The First Affiliated Hospital of Wenzhou Medical University
mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases
PHASE3Colorectal cancer patients with initially unresectable liver-only metastase...
Location
Zhongshan Hospital, Fudan University